Trials / Completed
CompletedNCT01275885
Vitamin D Intervention in Infants - Pilot
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 113 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aims of the present study are to evaluate the concentrations of vitamin D in the plasma and of calcium in the plasma and in the urine as well as to evaluate bone mineral density using peripheral quantitative computed tomography (pQCT), after supplementation of vitamin D with 30µg (1200 IU) and 40µg (1600 IU), in comparison with currently recommended supplementation of vitamin D with 10µg (400 IU). In this pilot study supplementation is given to infants from 2 weeks of age to 3 months of age.
Detailed description
Vitamin D deficiency is common around the world. In Finland vitamin D levels are low in all age groups. Especially infants are predisposed to vitamin D deficiency. Partly this is due to low exposure to sunlight but mainly it is due to low dietary intake of vitamin D. Vitamin D prophylaxis was introduced in Finland in the 1950´s to overcome rickets. However, the recommended dose has decreased from 50µg (2000 IU) in the 1960´s to 10µg (400 IU) from beginning of the 1990´s. The serum concentration of 25-hydroxyvitamin D (S-25OHD) is used as a marker of vitamin D status in the body. Although there is no consensus of optimal concentration of S-25OHD, it has been proposed that concentrations lower than 50 nmol/l indicate deficiency. According to recent findings on 25-OHD concentrations in Finnish children, currently recommended intake of vitamin D is inadequate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | cholecalciferol (D3) | 10µg (400 IU) orally daily for 10 weeks |
| DIETARY_SUPPLEMENT | cholecalciferol (D3) | 30µg (1200 IU) orally daily for 10 weeks |
| DIETARY_SUPPLEMENT | cholecalciferol (D3) | 40µg (1600 IU) orally daily for 10 weeks |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-05-01
- Completion
- 2011-06-01
- First posted
- 2011-01-13
- Last updated
- 2011-07-18
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01275885. Inclusion in this directory is not an endorsement.